Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was featured in a video segment discusses the combination products regulatory landscape.
The segment discusses the current regulatory landscape facing manufacturers of combination products. Thompson says that the FDA recently issued a long-awaited rule on current Good Manufacturing Practices, describes what the rule contains, and what it means for manufacturers. He also says more guidance from the agency is coming, but he is not sure when.